Nicole LaBrosse insider trades
Open-market stock purchases and sales by Nicole LaBrosse, SVP, CHIEF FINANCIAL OFFICER at Halozyme Therapeutics, Inc, from SEC Form 4 filings since Feb 10, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 23, 2026 | HALO Halozyme Therapeutics, Inc | Sold (not open market) | $255K |
| Feb 23, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
| Feb 20, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
| Feb 20, 2026 | HALO Halozyme Therapeutics, Inc | Sold (not open market) | $204K |
| Feb 16, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
| Feb 16, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
| Feb 16, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
| Feb 16, 2026 | HALO Halozyme Therapeutics, Inc | Sold (not open market) | $218K |
| Feb 16, 2026 | HALO Halozyme Therapeutics, Inc | Sold (not open market) | $228K |
| Feb 16, 2026 | HALO Halozyme Therapeutics, Inc | Sold (not open market) | $578K |
| Feb 9, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
| Feb 9, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
| Feb 9, 2026 | HALO Halozyme Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- HALO Halozyme Therapeutics, Inc: 12 sales, last Feb 23, 2026